![René Castro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
René Castro is currently the Chief Business Officer at Trinity Biosystems, Inc. He previously worked as the Director of Business Development at Exelixis, Inc., the Chief Business Officer at Anza Therapeutics, Inc., and as a Principal at Goldman, Sachs Commodities Corp.
Dr. Castro holds a Master's in Business Administration from Dartmouth College and an undergraduate and doctorate degree from the University of Miami.
| Unternehmen | Position | Ende |
|---|---|---|
Goldman, Sachs Commodities Corp. | Corporate Officer/Principal | - |
Anza Therapeutics, Inc.
 Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic vaccines for cancer and infectious diseases | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Trinity Biosystems, Inc.
 Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Develops and formulates orally delivered bio-therapeutic macromolecules | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Develops and formulates orally delivered bio-therapeutic macromolecules | Health Technology |
Anza Therapeutics, Inc.
Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic vaccines for cancer and infectious diseases | Health Technology |
Goldman, Sachs Commodities Corp. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
